Viewing Study NCT04651361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:56 PM
Ignite Modification Date: 2026-01-25 @ 9:30 PM
Study NCT ID: NCT04651361
Status: UNKNOWN
Last Update Posted: 2021-12-28
First Post: 2020-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Naldebain for Pain Control After Bariatric Surgery
Sponsor: E-DA Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain, Postoperative View
None Pain, Chronic View
None Bariatric Surgery View
None Obesity View
None Pharmacokinetics View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nalbupine View
None Dinalbuphine sebacate View
None Naldebain View
None Opioid View
None Laparoscopic gastric sleeve surgery View
None Laparoscopic gastric bypass surgery View